Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2015
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in Mixed cryoglobulinemia vasculitis, sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2015; status: terminated.
02
Drugs
rituximab
03
Conditions
Mixed cryoglobulinemia vasculitis
Beyond the preview
Go deeper on NCT02556866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556866.